Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)

Current therapies show limited efficacy against peritoneal metastases (PM) from pancreatic cancer. Pressurized intra-peritoneal aerosol chemotherapy (PIPAC) has emerged as a novel intraperitoneal drug delivery method. Recently, a dose-escalation study identified the safe dose of Nabpaclitaxel for PI...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Di Giorgio Andrea, Ferracci Federica, Bagalà Cinzia, Carbone Carmine, Salvatore Lisa, Strippoli Antonia, Attalla El Halabieh Miriam, Abatini Carlo, Alfieri Sergio, Pacelli Fabio, Tortora Giampaolo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	De Gruyter 2024-11-01
Edice:	Pleura and Peritoneum
Témata:	peritoneal metastasis pancreatic cancer pipac bidirectional chemotherapy combined chemotherapy locoregional chemotherapy
On-line přístup:	https://doi.org/10.1515/pp-2024-0010
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!